Cytek Biosciences (NasdaqGS:CTKB) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsBen Mee - Research AssociateBill McCombe - CFOPaul Goodson - Head of Investor RelationsSkye Gilbert - Equity Research AssociateWenbin Jiang - CEOConference Call ParticipantsAndrew Cooper - Director and Equity Research AnalystBrendan Smith - VP and Equity Research AnalystPaul GoodsonThank you, operator. Earlier today, Cytek Biosciences released financial results for the fourth quarter and year ended Dece ...

Company Overview - Cytek is a cell analysis company recognized for empowering scientific discovery in its field [3] - The company has been named one of the fastest-growing companies by Time Magazine and received accolades such as Company of the Year by the Chronicle Journal [3] Product and Achievements - Since launching its first instrument in 2016, Cytek has delivered over 3,000 instruments [4] - More than 3,000 technical journals have cited Cytek's technology as instrumental in their discovery work [4]